Genetic analysis can predict bleeding risk in warfarin users Genetic analysis can point to patients who are at increased risk of suffering from bleeding during treatment with the blood thinner warfarin, a study published in The Lancet confirms.…
Managing ANCA-associated vasculitis Treatment of vasculitis associated with antineutrophil cytoplasmic antibodies requires immunosuppressive therapies and close monitoring of the patient to manage toxicity.…
Prescribing statins: time to rein it in Statins have been overprescribed for decades for many different reasons. Now is the time to reverse the trend.…
HRT linked with increased stroke risk, conclude Cochrane reviewers HRT has little if any benefit in the prevention of cardiovascular disease and causes an increase in the risk of stroke and venous thromboembolic events.…
Paroxetine improves symptoms of heart failure in mice The selective serotonin reuptake inhibitor (SSRI) paroxetine inhibits G-protein-coupled receptor kinase 2, an enzyme that hastens the onset of heart failure.…
Low and high levels of vitamin D associated with cardiovascular deaths, study suggests The association between cardiovascular disease mortality and vitamin D levels has been investigated in an observational study.…
Genetic risk for coronary events linked to statin response Patients with high and intermediate genetic risk for coronary heart disease benefit more from statin therapy than patients at low genetic risk, researchers have shown.…
Low molecular weight heparins for treating venous thromboembolism How to start patients on these common injected anticoagulants and optimise treatment.…
Paracetamol use linked with cardiovascular risk and other adverse events Researchers have discovered a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events.…
Safety data prompt calls for a halt on NSAID use in patients with heart disease The use of nonsteroidal anti-inflammatory drugs in patients receiving antithrombotic therapy after myocardial infarction doubles the risk of further heart attacks, researchers find.…